Wednesday, September 03, 2025 11:29:15 AM
Lets see, 5 weeks ago it was new MHRA guidelines and we are allready approved. The following week it was we are half way through labeling. Then the following week it was new FDA program and we are 2 months from approval, Then the following week it was LP is selling her house and using money to buy stock in the future. Then the following week it was a roaring kitty type short squeeze. Then the following week it was lawsuit will bring billions, we are in discovery. Since all this has not occurred, that we know of, lets go back to the allways faithful "its fudsters and MM's fault" for SP.
If you look at the pattern, seems like always an early morning spike on hopes of news, followed by dilution dump, followed by market trying to absorb shares the rest of the day.
Some honest questions you might ask, if shorts were covering, why is SP going down? And number two, why are MM's stopping at .23( or less than a penny a day drop), if their goal is to bankrupt the company?
If you say they are still shorting company, then you have to ask, why would you short a company that is very close to UK approval?
For those saying approval is waiting for eden system, remember the application was filed using manual manufacturing.
I have no idea whats taking so long. so I will not guess. I will not pump and I will not create FUD. We have an application in the MHRA. Its for treatment of glioblastoma. We just acquired advent, which is good news. Thats where we stand. Put fudsters on ignore and just wait like everyone else. Now I will go out and enjoy the rest of the day. JMO
I find it very strange on the timing of advent merger. Those with money on the sidelines saw it as a sign and invested whatever they had left. Now I question how much is left to invest on approval? It seems like NWBO took advantage of the merger to dilute millions of shares at better SP, but they might have shot themselves in the foot in so doing. I have nothing left to invest on approval news. I saw that others also made large investments on advent news. Right now my hope is on approval, then B/O. Imagine another year of this with FDA submittal.
If you look at the pattern, seems like always an early morning spike on hopes of news, followed by dilution dump, followed by market trying to absorb shares the rest of the day.
Some honest questions you might ask, if shorts were covering, why is SP going down? And number two, why are MM's stopping at .23( or less than a penny a day drop), if their goal is to bankrupt the company?
If you say they are still shorting company, then you have to ask, why would you short a company that is very close to UK approval?
For those saying approval is waiting for eden system, remember the application was filed using manual manufacturing.
I have no idea whats taking so long. so I will not guess. I will not pump and I will not create FUD. We have an application in the MHRA. Its for treatment of glioblastoma. We just acquired advent, which is good news. Thats where we stand. Put fudsters on ignore and just wait like everyone else. Now I will go out and enjoy the rest of the day. JMO
I find it very strange on the timing of advent merger. Those with money on the sidelines saw it as a sign and invested whatever they had left. Now I question how much is left to invest on approval? It seems like NWBO took advantage of the merger to dilute millions of shares at better SP, but they might have shot themselves in the foot in so doing. I have nothing left to invest on approval news. I saw that others also made large investments on advent news. Right now my hope is on approval, then B/O. Imagine another year of this with FDA submittal.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
